This is the MIRB 2 Committee's suggested language for use of Rituximab. It can go in the "Potential Risks and Discomforts section of the consent form:
PML is one of the viral infections that may develop several months after treatment with Rituxan. PML is a rare and usually fatal disease that is characterized by brain damage that worsens over time. There are no known effective treatments for PML.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment